
DiagCor is proud to announce a major milestone in our European operations: Bulgaria's largest specialized molecular diagnostic laboratory has adopted a complete GenoFlowTM HPV workflow.
For almost ten years, the GenoFlowTM HPV Array has been the assay of choice at this facility for comprehensive HPV genotyping. Building on this foundation of trust, the laboratory recently conducted a thorough technical and economic evaluation of their screening capabilities. The result? They chose to discontinue their real-time PCR screening assay in favour of the GenoFlowTM HPV-HR Screening Test Kit.
This decision represents total conversion and adoption of DiagCor's HPV DNA solutions, and signals a strong market preference for the reliability and user-friendly design of the GenoFlowTM platform.
A Win for Partnership
This achievement would not have been possible without the instrumental support of our Bulgaria distributor. Their persistence, technical expertise, and deep understanding of the local market were the driving forces behind this expansion.
Calling All Distributors
Are you looking to replicate this success in your region? We invite our global distributor network to contact us to learn more about this project and discover how the GenoFlowTM workflow can win key accounts in your territory.
Acerca de DiagCor
Ubicados en Hong Kong, DiagCor se ha dedicado al desarrollo de pruebas moleculares (MDx) desde el 2006. Como líderes mundiales de la tecnología de hibridación rápida (flow-through hybridization), nuestra compañía ofrece una amplia gama de productos, soluciones y servicios relacionados con el análisis de ADN y ARN. Así mismo proveemos servicios de laboratorio MDx a médicos y profesionales en Asia Pacífica. DiagCor desarrolla y fabrica productos y soluciones MDx y a su vez ofrece consultoría en medicina translacional para proyectos MDx.
Contacto de prensa
DiagCor Life Science